Similar results have been observed in other populations with T2DM, including a Japanese cohort where ipragliflozin significantly improved the β-cell function assessed by an OGTT-derived disposition index and an Italian study where empagliflozin enhanced β-Cell glucose sensitivity and increased insulin clearance [7, 21]. This evidence concerns the gene INS and type 2 diabetes mellitus.